dc.creatorCoura, Renata dos Santos
dc.creatorNardi, Nance Beyer
dc.date2010-06-05T04:17:28Z
dc.date2008
dc.identifier1415-4757
dc.identifierhttp://hdl.handle.net/10183/23403
dc.identifier000630743
dc.descriptionGene therapy constitutes a therapeutic intervention based on modification of the genetic material of living cells, by correcting genetic defects or overexpressing therapeutic proteins. The success of gene therapy protocols depends on the availability of therapeutically suitable genes, appropriate gene delivery systems and proof of safety and efficacy. Recent advances on the development of gene delivery systems, particularly on viral vectors engineering and improved gene regulatory systems, have led to marked progress in this field. Although the available vector systems can successfully transfer genes into cells, the ideal delivery vehicle has not been found. In this context, adeno-associated virus vectors (AAV) are arising as a promising tool for a wide range of applications, due to a combination of characteristics such as lack of pathogenicity and immunogenicity, wide range of cell tropism and long-term gene expression. Since its isolation, the biological properties of the adeno-associated virus have been increasingly understood, improving our ability to manipulate and use it as a safe and efficient gene therapy vector of wide spectrum. In this work, we review the bases of gene therapy, main types of gene transfer systems and basic properties and use of AAV vectors.
dc.formatapplication/pdf
dc.languageeng
dc.relationGenetics and molecular biology. Ribeirão Preto. Vol. 31, n. 1 (Mar. 2008), p. 1-11
dc.rightsOpen Access
dc.subjectGenética
dc.subjectTerapia gênica
dc.subjectAdenovírus
dc.subjectAdeno-associated virus
dc.subjectAAV-based recombinant vectors
dc.subjectGene therapy
dc.titleA role for adeno-associated viral vectors in gene therapy
dc.typeArtigo de periódico
dc.typeNacional


Este ítem pertenece a la siguiente institución